Larry Bock

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Rexwevk (talk | contribs) at 16:25, 5 December 2014 (Created page with ''''Larry Bock''' has facilitating in starting or financing 40 early stage growth company, that combined have a market value of more than $30 billion<ref>{{cite w...'). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

Larry Bock has facilitating in starting or financing 40 early stage growth company, that combined have a market value of more than $30 billion[1]. He is also a donor, co-founder, and executive director of USA Science & Engineering Festival[2][3][4].

Bock has invested in several companies including: Acceleron Pharma, Aurora Biosciences, Biosym Technologies, ekoVenture. Gen-Probe, Gensia Pharmaceuticals, Genocea Biosciences, IDEC Pharmaceuticals Magen Biosciences, Oclassen Pharmaceuticals Plexikon Pharmaceuticals, Poland Partners, Sequana Therapeutics, Sapphire Energy, Siluria, Sirtris Pharmaceuticals, Software Transformation, and Viagene[5].

References

  1. ^ "Larry Bock". The Huffington Post. Retrieved 5 December 2014.
  2. ^ Thornton, Kelly (Wednesday, August 29, 2012). "Mr. Bock Goes To Washington And Takes The Science Expo With Him". Retrieved 5 December 2014. {{cite news}}: Check date values in: |date= (help)
  3. ^ "Larry Bock". luxcapital. Retrieved 5 December 2014.
  4. ^ "Join Festival Co-founder Larry Bock and Stem Experts for e-week twitter chat". USA Science Festival. Retrieved 5 December 2014.
  5. ^ "Larry Bock". Xconomy. Retrieved 5 December 2014.